Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
16.72
+0.20 (1.21%)
May 11, 2026, 10:54 AM EDT - Market open
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.73 billion as of May 11, 2026. Its market cap has increased by 96.87% in one year.
Market Cap
1.73B
Enterprise Value
1.23B
1-Year Change
96.87%
Ranking
Category
Stock Price
$16.72
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.73B, an increase of 145.56%. That is a compound annual growth rate of 16.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.71B | -11.17% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 1.76B |
| Recursion Pharmaceuticals | 1.75B |
| uniQure | 1.74B |
| Generate Biomedicines | 1.74B |
| Palvella Therapeutics | 1.74B |
| Viridian Therapeutics | 1.71B |
| Vericel | 1.70B |
| Innoviva | 1.70B |